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Acetobacter turbidans -Amino Acid Ester Hydrolase
HOWA SINGLEMUTATION IMPROVES AN ANTIBIOTIC-PRODUCING ENZYME*
Received for publication,October 14, 2005, and in revised form, November 21, 2005 Published, JBC Papers in Press,December 23, 2005, DOI 10.1074/jbc.M511187200
Thomas R. M. Barends‡, Jolanda J. Polderman-Tijmes§, Peter A. Jekel§, Christopher Williams‡, Gjalt Wybenga‡,
Dick B. Janssen§, and BaukeW. Dijkstra‡1
From the Laboratories of ‡Biophysical Chemistry and §Biochemistry, University of Groningen, Nijenborgh 4,
9747 AG Groningen, The Netherlands
The-amino acid ester hydrolase (AEH) fromAcetobacter turbi-
dans is a bacterial enzyme catalyzing the hydrolysis and synthesis of
-lactam antibiotics. The crystal structures of the native enzyme,
both unliganded and in complexwith the hydrolysis product D-phe-
nylglycine are reported, as well as the structures of an inactive
mutant (S205A) complexed with the substrate ampicillin, and an
active site mutant (Y206A) with an increased tendency to catalyze
antibiotic production rather than hydrolysis. The structure of the
native enzyme shows an acyl binding pocket, in which D-phenylgly-
cine binds, and an additional space that is large enough to accom-
modate the -lactammoiety of an antibiotic. In the S205Amutant,
ampicillin binds in this pocket in a non-productivemanner,making
extensive contacts with the side chain of Tyr112, which also partici-
pates in oxyanion hole formation. In the Y206A mutant, the Tyr112
side chain has moved with its hydroxyl group toward the catalytic
serine. Because this changes the properties of the -lactam binding
site, this could explain the increased-lactam transferase activity of
this mutant.
Thirty years ago, several bacterial strains, such as Acetobacter turbi-
dans andXanthomonas citri, were identified that were able to efficiently
produce semi-synthetic -lactam antibiotics from -lactam nuclei pro-
duced by fermentation, and synthetic acyl compounds with an -amino
group (1). Important antibiotics with such acyl chains include cepha-
lexin, cephadroxil, ampicillin, and amoxicillin. Given the difficulties in
preparing such antibiotics by chemical means (2), much effort has been
put into harnessing the-lactam antibiotic synthesizing activity of these
bacteria for application in the industrial production of antibiotics. It
appeared that this activity originated from enzymes preferentially
hydrolyzing esters of -amino acids, the -amino acid ester hydrolases
(AEHs)2 (3).
Because of its potential usefulness in antibiotic synthesis, the AEH
fromA. turbidans has been studied extensively, and it was the first of its
family for which the gene was cloned and overexpressed (4). The
sequence showed a GXSYXG active site motif (4), which is characteris-
tic of serine hydrolases of theX-prolyl dipeptidyl aminopeptidase family
(5). Labeling studies with a suicide inhibitor, sequence alignments, and
site-directed mutagenesis identified a catalytic triad of Ser205, Asp338,
and His370 in what was proposed to be a catalytic domain with an /-
hydrolase fold (6).
Recently, the crystal structure of theX. citriAEHwas solved (7). This
enzyme shares 63% sequence identity with the A. turbidans AEH. The
structure showed a tetrameric arrangement of monomers consisting of
three domains each: an /-hydrolase domain at the N terminus, a
helical cap domain, and a C-terminal jellyroll fold domain. The active
site indeed contained a Ser-His-Asp catalytic triad, the constituents of
which were found in their canonical positions in the /-hydrolase
domain. Furthermore, a putative oxyanion hole was found in which a
negative charge could be stabilized by a backbone amide and a tyrosine
hydroxyl group. Similar folds and arrangements of active site residues
were observed for the homologous cocaine esterase CocE (8) and Lac-
tococcus lactis X-prolyl dipeptidyl aminopeptidase PepX (9). A particu-
larly striking feature of the Xanthomonas AEH active site was a cluster
of three carboxylate residues, which are conserved among theAEHs and
were proposed to bind the positively charged -amino group of the
substrate from which the AEHs draw their name (7).
The coupling of acyl side chains to -lactams by AEHs most likely
proceeds through enzyme acylation at the catalytic serine residue by an
acyl compound, followed by transfer of this acyl group to the amino
group of an amino--lactam, through “aminolysis” of the acyl enzyme
(3, 4, 10, 11). However, the acyl enzyme can also be hydrolyzed, and the
synthesized antibiotic can also serve as substrate and be cleaved, as
indicated in Fig. 1. Thus, the hydrolysis of the ester and the product
occur as undesired side reactions (3, 11–13). Therefore, the AEH-cata-
lyzed synthesis of antibiotics requires a kinetically controlled scheme. In
such a scheme, the enzyme is added to a mixture of the acyl donor, e.g.
D-phenylglycine methyl ester, and the acyl acceptor, e.g. 6-aminopeni-
cillanic acid. All three reactions (synthesis of the antibiotic, hydrolysis of
the ester, and hydrolysis of the antibiotic) will occur simultaneously, but
after a certain period of time, a maximum in the antibiotic concentra-
tion is reached, at which time the reaction is stopped and the product
harvested. The kinetic parameters of the enzyme govern the maximum
level of antibiotic accumulation PSmax in such a process (14). Of crucial
importance is the ratio of the specificity constants of the enzyme toward
the acyl donor and the antibiotic, , which is defined as (kcat/Km)product/
(kcat/Km)acyl donor. For favorable antibiotic yield, needs to be as small as
possible. Another important factor is the ratio of the rates of synthesis
and hydrolysis, measured as the ratio of the initial rates, Vs/Vhini. At a
certain concentration of nucleophile, this ratio indicates the tendency of
the acyl enzyme to undergo aminolysis rather than hydrolysis. For opti-
mal antibiotic yield, Vs/Vhini needs to be maximal (14, 15). Kinetic work
has shown that mutation of Tyr206 to alanine decreases the unwanted
hydrolytic activity toward cephalexin in the Acetobacter enzyme (6).
The corresponding residue in the Xanthomonas AEH was proposed to
contribute to transition state stabilization with its main chain atoms (7).
* The costs of publication of this article were defrayed in part by the payment of page
charges. This articlemust therefore be herebymarked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
Theatomic coordinates and structure factors (codes 2B4K, 2B9V, 1NX9, and1RYY) havebeen
deposited in theProteinDataBank, ResearchCollaboratory for Structural Bioinformatics,
Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
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The Y206A mutant of Acetobacter AEH was further investigated in
terms of its usefulness as a biocatalyst for antibiotic production (16).
The presentwork reports the structure of theAEH fromA. turbidans,
aimed at understanding the precise mode of action of this enzyme. In
addition to the native structure, the structures of the complex with
D-phenylglycine, the Y206A mutant, and the inactive S205A mutant
complexed with the antibiotic ampicillin are reported, as are the effects
of the Y206A mutation on the kinetic parameters , Vs/Vhini, and PSmax.
The structures give insight into the catalytic residues, substrate binding,
and the effects of mutations. In particular, the structure of the Y206A
mutant helps to explain the higher ratio of the rates of synthesis and
hydrolysis that this mutant displays.
EXPERIMENTAL PROCEDURES
Protein Production—Plasmids, bacterial strains, growth conditions,
and purification methods for the production of native, S205A, and
Y206A A. turbidans AEH with a C-terminal myc epitope and His tag
were as described in Ref. 6. Briefly, proteins were produced in
Escherichia coli TOP10 cells carrying constructs derived from pBAD.
Cells were grown at 14 °C for 4 days in LB medium with 100 g/ml
ampicillin and 0.01% (w/v) arabinose for induction.After harvesting and
washing, cells were either sonicated or passed through a French press
and a clear lysate was prepared by centrifugation. AEH and mutant
AEHs were purified from this lysate by metal ion affinity chromatogra-
phy using nickel-nitrilotriacetic acid-agarose (Qiagen). A stepwise gra-
dient of 50–200 mM imidazole in 150 mM NaCl, 50 mM sodium phos-
phate, pH 7.4, was used for elution. Pure protein eluted around 75–100
mM imidazole. Subsequently, the protein was desalted using gel filtra-
tion. Determination of the oligomeric state was carried out by gel filtra-
tion on a Superdex 200 column equilibrated with 50 mM sodium phos-
phate buffer, pH 6.2, containing 200 mM sodium chloride. Elution
volumes were calibrated using Bio-Rad gel filtration markers.
Determination of Kinetic Parameters—For the determination of
enzyme behavior in a cephalexin synthesis reaction, the enzymes were
incubated with 15 mM D-phenylglycine methyl ester (D-PGM) and 30
mM -lactam nucleus 7-amino-desacetoxycephalosporanic acid in 50
mM Na-phosphate buffer, pH 6.2, at 30 °C. Kinetic parameters for
cephalexin hydrolysis were previously reported in Ref. 6 and are given
here for reference. The synthesis of cephalexin and the hydrolysis of
D-PGM were followed by high performance liquid chromatography as
described before (4). Enzymes were used at a concentration that cata-
lyzed the hydrolysis of D-PGM with an initial rate of 0.20 to 0.30
mM/min. To obtain the rate of enzymatic D-phenylglycine production,
the observed rate of D-phenylglycine production was corrected for the
first-order chemical hydrolysis of D-PGM. The relative rate of antibiotic
formation versus hydrolysis of D-PGM (Vs/Vhini) was determined from
the initial slope of antibiotic formation divided by the rate of enzymatic
formation of the hydrolysis product (D-phenylglycine). The rates were
measured at less than 10% conversion of D-PGM to minimize the influ-
ence of product hydrolysis. The kinetic parameters Km and kcat were
calculated using nonlinear regression fitting (Scientist, Micromath)
with Michaelis-Menten and substrate inhibition kinetics. The calcu-
lated parameters are given with their standard deviations. The maxi-
mum product concentration (PSmax) was determined by following the
concentrations of cephalexin and D-phenylglycine over time, until the
product concentration started to decrease. All measurements were at
least performed in duplicate.
Crystal Preparation—His-tagged native andmutant AEHs were con-
centrated to 5 mg/ml by ultrafiltration. WT A. turbidans AEH and the
Y206Amutant were crystallized by mixing 3 l of protein solution with
3 l of 15–17% PEG 4000, 0.2 M ammonium acetate, 0.1 M sodium
acetate buffer, pH 4.6, followed by equilibration against this PEG solu-
tion. Prism-shaped crystals of WT protein of maximum dimensions
0.2  0.05  0.05 mm were obtained in 1 week. Plate-shaped crystals
(0.2 0.2 0.01 mm) of the Y206Amutant were obtained in 4 days. In
an attempt to obtain a complex with a substrate, WT crystals were
transferred tomother liquor containing 10mg/ml ampicillin for 30min
after which they were cryoprotected by soaking for a few seconds in the
FIGURE 1. Synthesis of antibiotics as catalyzed
by AEHs. The enzyme is acylated by an activated
acyl compound, e.g. an ester. The resulting acyl
enzyme can be hydrolyzed, resulting in a carbox-
ylic acid. Alternatively, the acyl enzyme may be
aminolyzedby an amino--lactam, resulting in the
desired antibiotic. The partitioning between ami-
nolysis and hydrolysis determines the Vs/Vh
ini. The
product may also react with free enzyme to form
acyl enzyme that can be hydrolyzed. The synthesis
of cephalexin from D-phenylglycine methyl ester
and 7-amino-desacetoxycephalosporanic acid is
(7-ADCA) shown as an example.
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same solution containing 25% glycerol, and cryocooled in liquid nitro-
gen. Y206A crystals were subjected to the same procedure, substituting
D-phenylglycine methyl ester for ampicillin. Crystals of a S205A
mutant-ampicillin complex were grown by mixing 3 l of protein solu-
tion with 3 l of a reservoir solution containing 0.3 M sodium citrate
buffer, pH 5.6, 13–14% PEG 4000, and 10 mM sodium ampicillin, fol-
lowed by equilibration in hanging drops against 500 l of this latter
solution for 3–4 days. Rhombic dodecahedra with a size of 0.3 0.3
0.3mmwere harvested and cryocooled after soaking for 30 s in reservoir
solution containing 26% glycerol.WTD-phenylglycine complex crystals
were grown in the same way, substituting WT protein for the mutant
and D-phenylglycine for ampicillin. All crystallization and soaking
experiments were carried out at room temperature.
DataCollection and Structure Solution—Useful diffraction data from
WT, WTD-phenylglycine, and Y206A crystals were collected to 2.0-,
3.3-, and 2.8-Å resolution, respectively, on beam line ID14-4 at the ESRF
inGrenoble, France. Diffraction data from crystals of the S205Amutant
co-crystallized with ampicillin were collected to 2.2-Å resolution on the
BW7B beam line of the EMBL outstation at the DESY synchrotron in
Hamburg,Germany.All datawere processedwithDENZOand SCALE-
PACK (17). The structure of theA. turbidansAEHwas solved bymolec-
ular replacement, using the program AMoRe (18) and the previously
determined tetrameric structure of the X. citri AEH as a search model.
The structure determination of theWT protein was hampered by twin-
ning in combination with pseudo-crystallographic translation symme-
try, and the structure elucidation process followed with this protein is
further described in Ref. 19. Briefly, a high twinning fraction was
observed, which made it impossible to detwin the data mathematically.
Therefore, the twinning was idealized by averaging intensities of twin-
related reflections (20) and the structure of the one twin domain, solved
by molecular replacement, was used to obtain detwinned intensities for
refinement. It should be noted, that because the measured data are
relatively incomplete (85.5% completeness), not all twin-related reflec-
tion pairs could be averaged for lack of availability of one of the reflec-
tions. After averaging and detwinning, this leads to the availability of
only 75% of all possible reflections for refinement. However, this num-
ber of available reflections corresponds to the number of reflections that
a 100% complete dataset of 2.2-Å resolution from this crystal would
have, thus effectively limiting the resolution to 2.2 Å. The twinning
also results in the loss of independence of twin-related reflections, low-
ering the observation/parameter ratio further. However, there are 16
AEHmonomers in the asymmetric unit (four AEH tetramers), enabling
the use of tight 16-fold non-crystallographic symmetry restraints, which
ensures that the refinement problem is sufficiently well determined.
Final models of all proteins were obtained through iterative cycles of
refinement with Refmac 5.0 (21), combined with rebuilding in Xfit (22).
During refinement of the Y206A mutant structure, 8-fold non-crystal-
lographic symmetry restraints were employed. Data collection and
refinement parameters are given in Table 1.
RESULTS ANDDISCUSSION
Native Structure: Oligomeric State—The structures of the WT,
WTD-phenylglycine, Y206A, and S205A AEH were successfully deter-
mined by x-ray crystallography. Despite different space groups and
crystallization conditions, all structures showed the same tetrameric
arrangement of monomers (Fig. 2a), which was also observed for the X.
TABLE 1
Data collection and refinement statistics
Where applicable, values for the highest resolution shell are given in parentheses.
Data collections WT WT-D-phenyl-glycine S205A-ampicillin Y206A
Statistics
Protein Data Bank code 2B9V 2B4K 1NX9 1RYY
Wavelength (Å) 0.933 0.934 0.8463 0.9393
Space group and cell dimensions P21, a 98.4,
b 275.6, c 197.0 Å,
 90.1°
I23, a b c
341.0 Å, 
  90°
I23, a b c 341.8 Å,
   90°
P21, a 91.6, b
177.5, c 170.0 Å,
 91.0°
Resolution range (Å) 40–2.0 40–3.0a 99–2.2 40–2.8
No. of unique reflections 598,744 121,384 322,911 134,932
Completeness (%) 85.5 (67.8) 93.2 (91.5) 97.2 (84.3) 99.4 (99.6)
Redundancy 2.8 2.6 4.5 3.2
Rsym 0.091 (0.341) 0.186 (0.917) 0.081 (0.322) 0.066 (0.184)
I/ 6.6 (1.5) 7.1 (2.8) 14.3 (3.7) 17.2 (6.9)
Refinement statistics
Residue range in refinement (Å) 40–2.0b 15–3.3 15–2.2 40–2.8
No. reflections in refinement 504,379 91,758 304,675 125,967
Protein atoms 77,072 19,536 19,532 39,016





Ampicillin, 96 (4 molecules);
glycerol, 24 (4 molecules)
0
R-factor 0.199 0.258 0.166 0.253
Rfree 0.235 0.289 0.184 0.272
Root mean square deviations from ideal
geometry
Bonds (Å) 0.008 0.009 0.007 0.009
Angles (°) 1.7 1.0 1.1 0.8
Ramachandran plot
Most favored 87.0% 82.7% 86.0% 84.1%
Additional allowed 12.6% 17.1% 13.6% 15.4%
Disallowed (these include catalytic and
structurally important residues)
0.3% 0.2% 0.4% 0.4%
a Due to the high merging R-factor at 3.0-Å resolution, only data to 3.3-Å resolution were used for refinement.
b The data used for the refinement of the WT structure are only 75% complete due to collection geometry and detwinning; however, the number of reflections used in the
refinement of this structure corresponds to the number of reflections in a 100% complete dataset to 2.2-Å resolution.
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citri AEH (7). Gel filtration experiments with the WT protein and the
S205A mutant indicated the presence of exclusively tetramers in solu-
tion, reinforcing the notion that the crystallographically observed tet-
ramer represents the physiological oligomerization state.
The Acetobacter AEH tetramer (Fig. 2a) has the shape of a hollow
sphere with a diameter of about 100 Å. The central cavity can only be
reached through two diametrically opposed entrances that are each
15 Å wide. Because the active sites are found on the inside of the
sphere, this tetrameric oligomerization state would restrict the AEHs to
converting small compounds.
The native structure of the Acetobacter AEH monomer (Fig. 2b)
resembles that of the Xanthomonas AEHmonomer. It can be superim-
posed with XanthomonasAEH to within a root mean square difference
of C positions of 4.5 Å. Like the Xanthomonas enzyme, it includes an
N-terminal arm, an /-hydrolase domain with a helical cap domain,
and a C-terminal jellyroll fold domain. The N-terminal arm consists of
24 residues that form an elongated polypeptide that interacts with the
surface of another monomer. Residues 62–73, in the middle of the arm,
could not be identified in the electron density map. These residues span
the gap between the two monomers held together by the arm, and may
thus be expected to be mobile, because they make no non-bonded con-
tacts with either monomer. However, their approximate positions can
be inferred from the short distance between the beginning and end of
this gap and their better defined positions in the S205A mutant
structure.
The arm is followed by a typical /-hydrolase fold domain, consist-
ing of a highly twisted -sheet flanked on both sides by -helices (23–
25). Apart from the second one, all strands in the sheet are parallel.
Adopting the nomenclature in Ref. 23, the catalytic residues Ser205,
His370, and Asp338 are found at their canonical positions on the loops
between strand 5 and helix C, between 8 and F, and between 7
and E, respectively. Compared with the classical /-hydrolase fold,
which has eight -strands in the central sheet, AEH displays two addi-
tional -strands at the C terminus of the domain. Furthermore, several
insertions are seen, most notably a predominantly helical cap domain
between6 andD.Another insertion between3 andAcontains the
conserved Tyr112, which is in a position to contribute with its hydroxyl
group to oxyanion stabilization during the reaction. The C-terminal
domain adopts a jellyroll fold with several insertions, one of which con-
tains a helix that approaches the active site as in the X. citri AEH.
Active Site Structure—The active site is found at the interface of the
/-hydrolase, cap, and jellyroll domains. The catalytic Ser205 is located
on the so-called nucleophile elbow between 5 and C and has unfa-
vorable main chain dihedrals as is usual in /-hydrolase family mem-
bers (25). It is closely approached by His370, which in turn is hydrogen
bonded to Asp338. Thus, a canonical Ser-His-Asp catalytic triad is
formed. The backbone amide of Tyr206, which directly follows the cat-
alytic serine in the sequence, and the phenolic OH of the Tyr112 side
chain form an oxyanion hole similar to that observed in X. citri AEH,
CocE, and PepX (7–9). As in these proteins, Tyr112 makes stacking-like
interactions with the Pro111 ring, as does Tyr206 on the other side of the
Pro111 side chain (figure 3a). The Tyr112 side chain is further restrained
by a hydrogen bond with the Tyr253 side chain (not shown).
Close to the active serine, a pocket is present, delineated by residues
stemming mostly from the cap domain. It is found in the position were
the acyl chain would be expected in an acyl-enzyme compound. In a
FIGURE 2. a, stereo figure of the A. turbidans -a-
mino acid ester hydrolase tetramer. A surface rep-
resentation is shown, in which each monomer is
individually colored. b, stereo figure of theA. turbi-
dans -amino acid ester hydrolase monomer. The
arm and /-hydrolase domains are shown in
green, the cap domain in orange, and the jellyroll
domain in blue. The side chain of the active site
Ser205 is shown in space filling representation. Hel-
icesC–Fand strands4–7are labeled. The fig-
urewaspreparedusingPYMOL (DeLanoScientific)
and Molscript (30).
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difference Fourier synthesis using data collected from an AEH crystal
grown in the presence of D-phenylglycine, strong difference density was
observed in three of four active sites of the tetramer, consistent with
D-phenylglycine binding to this site, again pointing to this pocket being
the acyl chain binding site (Fig. 3b). In the complex, the aromatic ring of
phenylglycine makes stacking interactions with Tyr253. On the other
side of the catalytic serine, a much larger space is observed, which could
accommodate a bulky leaving group during the enzyme acylation step of
the reaction, and could bind a large acyl acceptor during the enzyme
deacylation step.
Substrate Specificity—On one side of the putative acyl binding
pocket, a cluster of acidic residues was observed (Fig. 3b). These resi-
dues (Asp239, Glu340, and Asp341) form the conserved cluster proposed
to recognize the -amino group of the substrate (7) and can be super-
imposed with the corresponding residues of the X. citri AEH to a root
mean square deviation of 0.88 Å. In the difference electron density
observed in the AEHD-phenylglycine complex, D-phenylglycine could
be placedwith its ammoniumgroup close to the acidic residues (Fig. 3b).
Interestingly, despite the presence of a canonical catalytic triad, com-
pounds that lack an -amino group are not normally converted. Also,
AEH is not inhibited by the neutral reagent phenylmethanesulfonyl
fluoride, but it is inhibited by p-nitrophenyl-p-guanidinobenzoate (6),
which carries a positive charge in solution at neutral pH. These obser-
vations can be explained in two ways. First, the binding of a neutral
substratewould bury the three carboxylate groups of the clusterwithout
neutralizing their negative charge, which would be energetically unfa-
vorable. Second, the distance between the Asp239 O and the catalytic
Ser205 O is only 3.5 Å. The close proximity of the negatively charged
Asp239 O would severely decrease the nucleophilicity of Ser205 O by
inhibiting its deprotonation by the catalytic His/Asp combination,
thereby precluding the acylation reaction unless the charge of Asp239 is
compensated by a positive amino group on the substrate. These effects
would also explain why AEHs convert esters of phenylglycine, but are
not inhibited by phenyl acetic acid, which differs from phenylglycine
only in the absence of the -amino group.
Effects of Mutations—Previously, several important residues in AEH
were identified by site-directed mutagenesis. Specifically, the influence
of mutation of the GXSYXG consensus motif was investigated, which
helped to identify the catalytic serine 205. Mutation of this residue
almost completely abolished activity (4, 6). The crystal structure of the
S205A mutant shows no appreciable differences in side or main chain
conformations in the active site compared with the native enzyme.
Thus, its inactivity is solely because of the loss of the Ser205 hydroxyl
group.
As mentioned above, previous work identified Tyr206 as a candidate
for mutation in the development of AEH mutants with improved bio-
catalytic properties. Kinetic parameters for the wild-type enzyme and
the Y206A mutant were determined and are reported in Table 2. Com-
pared with wild-type enzyme, the Y206A mutant shows a reduced kcat
toward both cephalexin and D-phenylglycine methyl ester. Further-
more, it displays a 3-fold increase in the ratio of the initial rates of
FIGURE 3. a, stereo figure showing the active site
residuesofA. turbidansAEH. Thecatalytic triadand
the residues forming the oxyanion hole are shown
in stick representation. An asterisk indicates the
expected position of the oxyanion hole. The 2Fo
Fcelectrondensitymap is overlaidon the structure
at a 1.0- contour level. b, stereo figure, showing
(Fo  Fc) difference electron density calculated
with the D-phenylglycine co-crystal data prior to
including D-phenylglycine in the model, overlaid
on the refined D-phenylglycine complex structure.
The ammonium group of D-phenylglycine is in
close proximity to the carboxylate cluster. c, stereo
figure comparing the active site residues of WT
(gray) and Y206A (blue) AEH. Transparent spheres
indicate the vanderWaals radii of the atoms of the
interacting Tyr112 and Asn257 residues in the
Y206A structure. The changes upon the mutation
of Tyr206 to Ala are indicated with numbers: 1,
mutation of Tyr206 to Ala; 2, loss of the hydrogen
bond with Tyr160; 3, movement of the Gln257 side
chain; 4, van der Waals interactions of Gln257 side
chainwithTyr112 side chain;5,movementof Tyr112
side chain toward oxyanion hole; 6, possible
hydrogen bond between Tyr112 O and Ser205 O.
The figure was prepared using Xfit (22), BobScript
(31), and Raster3D (32).
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synthesis and hydrolysis (Vs/Vhini during cephalexin synthesis as well as a
60% increase in maximum cephalexin accumulation.
Tyr206 is part of the so-called nucleophile elbow and is believed to
stabilize the oxyanion of the tetrahedral transition state with its back-
bone amide (7), whereas its side chain points into the protein, away from
the active site cavity. However, the backbone conformations of the
nucleophilic elbows of the wild-type and Y206A proteins show no large
differences. Thus, the altered catalytic properties of this mutant are
difficult to explain through a direct effect of the Tyr to Ala mutation.
They can, however, be explained by indirect effects on the local struc-
ture (see Fig. 3c). In the native structure, the buried Tyr206 side chain
forms a hydrogen bond with another buried tyrosine, Tyr160. In the
Y206A mutant, the loss of the hydrogen bonding partner of Tyr160 is
compensated for by a rearrangement of Gln257 on the surface of the
protein. A180° rotation around the C-C bond, and an80° rotation
around the C-C bond point the Gln257 O-1 atom into the protein,
where it hydrogen bonds with the buried Tyr160. However, in the wild-
type structure the Gln257 side chain is in close proximity to the side
chain of Tyr112, which is believed to contribute to stabilizing the oxya-
nion developing during catalysis (7). In the mutant, the rearrangement
of the Gln257 side chain causes a significant shift of the Tyr112 side chain
toward the catalytic serine (see Fig. 3c). Thus, the distance between the
Tyr112 O and the reactive Ser205 O becomes on average 3.4 Å in the
mutant, corresponding to a weak hydrogen bond, whereas in the wild-
type enzyme, this distance is on average 4.5 Å. The close interaction in
the mutant will lower the nucleophilicity of the serine O, rendering it
less reactive, which would explain the reduced kcat values of the Y206A
mutant enzyme. Additionally, the observed decrease in activity can be
explained by a less favorable positioning of the Tyr112 hydroxyl group
for transition state stabilization. In either case, the mutation of one of
the two oxyanion hole-forming residues perturbs the position of the
other, thus affecting the properties of the oxyanion hole indirectly.
The explanation of the increase in the ratio of the initial rates of
synthesis and hydrolysis (Vs/Vhini) during cephalexin synthesis is less
straightforward. Apparently, the mutation affects the interaction of the
acyl enzyme with the competing nucleophilic acyl acceptors, water and
the -lactam nucleus, by altering the way in which the acyl enzyme is
presented to an acyl acceptor, or the way in which the acceptor is bound
and/or activated. Possibly, the geometry of the atoms around the scissile
bond between enzyme and acyl group is changed to favor attack by a
-lactam rather than by water (26). An alternative explanation is that
Tyr112 participates directly in binding the acceptor, in which case a
change in the position of Tyr112 could affect both binding affinity and
binding mode.
Indeed, the Tyr112 phenol ring is part of the surface of the site where the
-lactam part of the product would be expected to bind. The involvement
of Tyr112 in -lactam binding has been proposed for the X. citri AEH (7).
Interestingly, in the homologous PepX (9), the corresponding residue is in
themiddleof a largehydrophobicpatchon the surfaceof the active site, and
could thus play a role in substrate binding in this case as well. The corre-
sponding tyrosine in the homologous CocE has been proposed to interact
with the leaving group part of the substrate in cocaine hydrolysis, too (27).
Participation of this tyrosine residue in substrate binding wouldmean that
it plays a dual role in that apart from oxyanion stabilization through the
main chain amide, its side chain also interacts with a different part of the
substrate, at other stages in the reaction.
The higher maximum product accumulation in antibiotic synthesis
by the Y206Amutant has been attributed to a decrease in the affinity of
the enzyme for the antibiotic (6, 16). This, too, could be caused by an
altered positioning of Tyr112 influencing its affinity for a -lactam.
Ampicillin Binding Mode—Crystals of the inactive S205A mutant
were grown in the presence of ampicillin, and Fo Fc and 2Fo Fcmaps
calculated after refinement of the initialmolecular replacement solution
showed an ampicillin molecule bound in the active site of each mono-
TABLE 2
Kinetic properties of WT and Y206A AEH
Kinetic parameters for cephalexin hydrolysis, D-phenylglycinemethylester (D-PGM) hydrolysis, with the specificity ratio  , and the ratio of the initial rates of synthesis and
hydrolysis Vs/Vhini and maximum product concentration PSmax in a kinetically controlled cephalexin synthesis reaction.
D-PGM hydrolysis Cephalexin hydrolysis (from Ref. 6) Cephalexin synthesis from D-PGM/7-ADCAa
kcat Km kcat/Km kcat Km kcat/Km  Vs/Vhini Psmax
s1 mM s1 mM s1mM1 mM
WT 1067 56 1 0.1 1067 121 274 7 0.45 0.06 609 83 0.6 2.4 0.8 5.4 0.1
Y206A 655 39 5.3 0.9 124 22 120 2 4.0 0.2 30 2 0.24 9 2 8.6 0.6
a 7-ADCA, 7-amino-desacetoxycephalosporanic acid.
FIGURE 4.Stereopicture of the 2Fo Fc electron
density of ampicillin in the active site of the
S205A mutant, after refinement of the initial
molecular replacement solution, prior to inclu-
sion of ampicillin in the model. The density was
contoured at 1.0 , and overlaid on the final
refined structure. The figure was prepared using
Xfit (22) and Raster3D (32).
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mer. The antibiotic predominantly makes hydrophobic contacts with
Tyr112, both with its acyl chain and its -lactam moiety (Fig. 4). Addi-
tional interactions are made with Tyr375, Ser371, Arg117, and Glu207. The
carbon atom of the scissile amide bond is10 Å away from the Ala205
C, indicating that in the native protein, attack by Ser205 would not be
possible in this binding mode. Perhaps, the non-productive binding
mode of ampicillin in the AEH active site is caused by the high glycerol
concentration used to cryoprotect the crystal. Electron density compat-
ible with a glycerol molecule is observed in the putative acyl binding
pocket, suggesting that the glycerol has displaced the ampicillin from its
productive binding site into the position observed. Although ampicillin
does not bind in a productive mode in the S205A structure, this result
does show the propensity of Tyr112 for ligand binding.
Conclusions and Outlook—The structure determination of the A.
turbidans-amino acid ester hydrolase and of twomutants has resulted
in a view of an active site that combines a classical catalytic triad with
unusual elements like a cluster of acidic residues and an oxyanion hole
with a tyrosine side chain contribution. In detail, the structures show
howmutation of Tyr206 to alanine results in a shift in position of Tyr112,
altering both the oxyanion hole and the surface of the leaving group
binding pocket. Given the effects of this mutation on the synthesis/
hydrolysis ratio and the binding of antibiotics, this result points to a
function for Tyr112 in leaving group/acceptor binding next to its pro-
posed function in oxyanion stabilization.
Additional research focused on improving the catalytic properties of
AEHs could be directed toward understanding themolecular details of the
hydrolysis reaction. Papers describing both crystallographic (28) and sim-
ulation (29) studies of serineproteases have suggested that in such enzymes
the attackingwatermolecule is first bound to the protein in a position close
to the acyl enzyme ester bond and the catalytic histidine. It is then activated
by the histidine, and attacks the ester bond. Looking at candidate “landing
platforms” for suchawatermolecule in theAEHstructures yields aposition
close to Ser371. In five of the 16 monomers in the wild-type structure, a
watermolecule is observed hydrogen bonded to the Ser371 side chain, close
to the catalytic histidine N-2, by which it could be activated for attack. In
theA. turbidansAEHS205A-ampicillin complex, this position is occupied
by an oxygen atom of ampicillin. In the X. citri AEH structure, a water
molecule was observed in the corresponding position, too. Identifying a
hydrolytic water molecule in AEHmight allow additional mutations to be
made that reduce the hydrolysis rate and lead to even better catalytic
properties.
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